AN ORAL PAN-AKT INHIBITOR IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS SHOWS SIGNS OF CLINICAL ACTIVITY

R. J. Arceci
C. Allen
I. Dunkel
E. Jacobsen
J. Whitlock
R. Vassallo
I. Borrell
S. Morris
B. A. Reedy
A. Portnoy
B. Noble
A. Murnane
S. Szabo
C. Rodriguez-Galindo
K. McClain
S. Vaiselbuh

Abstract